Description
Most fish oil products give you EPA and DHA from a standard marine oil concentrate and stop there. EPAX® Omega 3-9-11 is a specific deep-sea concentrate that delivers EPA and DHA alongside two long-chain monounsaturated fatty acids — gondoic acid (20:1n-9) and cetoleic acid (22:1n-11) — that are naturally present in species like capelin and herring but refined out of the commodity fish oil supply chain. These LCMUFAs are emerging in the cardiovascular and metabolic research literature with independent mechanisms distinct from EPA and DHA, and they’re essentially absent from anything sold as standard omega-3. EPAX is pharmaceutical-grade Norwegian concentrate — the source behind prescription omega-3 formulations, with the purity and oxidation standards that matter when you’re recommending long-term daily use to patients.
The EPA:DHA ratio here is approximately 2:1 — 1000mg EPA to 500mg DHA — which is a deliberate formulation choice. EPA drives the anti-inflammatory eicosanoid pathways most relevant for the presentations I see most often: hormone-related inflammation, mood, and cycle-associated inflammatory burden. DHA is critical for neurological and cognitive function but is the more structurally focused fatty acid. For the patient who needs both broad inflammatory support and cognitive support, this ratio covers both without skewing too far toward either. I recommend this as a foundational daily formula for almost any patient — the EPAX sourcing standard means I’m confident in what’s actually in the softgel, and the omega-9/11 inclusion is the clinical detail that separates it from the fish oil they’re likely already aware of.
